Cancer cells in blood predict chances of survival and can help target breast cancer treatment
2012-03-22
(Press-News.org) Vienna, Austria: Detecting the presence of circulating tumour cells (CTCs) in the blood of women with early breast cancer after surgery but before the start of chemotherapy can provide useful information about their chances of surviving the disease. CTCs are cancer cells which are detectable in patients with a solid tumour and their value in the prognosis of metastatic breast cancer has been known for a few years. Until now, however, there has been little information about their role in early disease.
Results to be presented today (Thursday) from the first large-scale study of the relevance of CTCs in early breast cancer prognosis show that patients with at least five CTCs detected straight after surgery have a four-fold increase in risk of recurrence and a three-fold increase in risk of death. Dr. Bernadette Jäger, from the Department of Gynecology and Obstetrics – Innenstadt, Ludwig Maximilian University Hospital Munich, Germany, will tell the 8th European Breast Cancer Conference (EBCC-8) that, in addition to helping provide a more accurate evaluation of disease outcome, CTCs might also become targets for treatment in the future.
Dr. Jäger and colleagues from nine German university hospitals analysed the numbers of CTCs in the blood of 2026 patients in a trial called SUCCESS A. The patients had all had a complete resection of their primary tumour prior to commencing chemotherapy. CTCs were detected in 21.5% of them, a much lower rate than that which is usually seen in metastatic breast cancer.
Because the numbers of CTCs in blood are very small, their detection is difficult – they are found in frequencies in the order of 7.5 per millilitre of blood in cancer patients. In comparison a millilitre of blood contains a few million white blood cells and a billion red blood cells. However, recent advances in technology have meant that it is possible to find CTCs using a semi-automated detection device.
"From the patient's point of view looking for CTCs in blood samples is much less invasive than taking bone marrow, the other means of evaluating them," Dr. Jäger will say. "So although there is currently no direct advantage to the patient of knowing her CTC status, this is already a step forward, and in future we believe that the presence of CTCs could be used as a marker for monitoring the efficacy of treatment. If this proves to be the case, it will also help us determine the best chemotherapy regime for each patient."
CTC detection in blood also has the advantage that it can be combined with any routine blood collection and therefore carried out frequently during the course of disease, unlike many other predictive measures, which are carried out at diagnosis alone, the researchers say. They are following up their work by evaluating CTC counts of patients straight after chemotherapy and at intervals of two and five years later.
In addition, Dr. Jäger and colleagues have just started a new trial, DETECT III. "In this trial we will be looking at the effect of adding a secondary drug, lapatinib, to standard treatment in patients with HER2-negative metastatic breast cancer and HER2-positive CTCs," Dr. Jäger will say. Over-expression of the HER2 (human epidermal growth factor receptor 2) gene has been shown to play an important role in the progression of certain aggressive types of breast cancer, and its existence is a significant target for therapy.
"We know that HER2 status can change as the disease advances. However, if there is no relapsed tumour in the primary cancer site it is difficult to perform a.new histopathological examination. Being able to detect this change in CTCs would be much less invasive than having to take a biopsy of a metastasis which is often anatomically inaccessible. When we find CTCs with a different HER2 status from that of the primary tumour or the metastasis, we will evaluate the advantage of changing the therapy regimen. Therefore we are now investigating the benefit of an HER2 targeted therapy in patients with HER2 positive CTCs but a HER2 negative primary tumour or metastasis; if the therapy is successful we can be sure that we are attacking the cancer in the right way and in the right place."
"If CTCs can be used as a direct treatment target, this will be a promising development and a further step on the road to enabling us to tailor treatment appropriately for individual patients", Dr. Jäger will conclude.
Professor Michael Gnant from the Medical University of Vienna (Vienna, Austria) and Chair of the EBCC Organising Committee said: "Accurately identifying circulating tumour cells is an important step forward in our two-decade-long quest to decipher these cells and their impact on treatment response and prognosis of early breast cancer patients. The excellent work by Dr. Jäger and her colleagues provides reassurance that we might be approaching an era where these serum-based tests can be used in clinical practice to help monitoring the effects of our treatments."
INFORMATION:
END
ELSE PRESS RELEASES FROM THIS DATE:
2012-03-22
Door2Tour.com has revealed that the 'staycation' could be making a comeback. The latest figures from the tour operator have shown that sales of UK breaks have increased by approximately 9% compared to the same period last year. This has been put down to the UK being under the spotlight during 2012.
There are a variety of factors causing this resurgence in UK breaks with the main one being the UK playing host to some top events during 2012 such as the Queens Diamond Jubilee, The Olympics, the 100th anniversary of the maiden voyage of RMS Titanic and the 200th anniversary ...
2012-03-22
Vienna, Austria: Women aged 50 and over with breasts that have a high percentage of dense tissue are at greater risk of their breast cancer recurring, according to Swedish research presented at the eighth European Breast Cancer Conference (EBCC-8) in Vienna today (Wednesday).
Dr Louise Eriksson and her colleagues from the Karolinska Institutet (Stockholm, Sweden) found that women with denser breasts had nearly double the risk of their cancer recurring, either in the same breast or in the surrounding lymph nodes, than women with less dense breasts. They warn that doctors ...
2012-03-22
Vienna, Austria: Results from one of the longest-running national breast cancer screening programmes have shown that it has contributed to a drop in deaths from the disease, that any harm caused by the screening, such as false positives and over-diagnosis, has been limited, and that the costs have been reasonable.
The Dutch population-based mammography breast cancer screening programme began in 1989, and today (Wednesday) Mr Jacques Fracheboud, a senior researcher at the Erasmus University Medical Center (Rotterdam, The Netherlands), reported on the first 20 years to ...
2012-03-22
Vienna, Austria: Adding magnetic resonance imaging (MRI) to standard breast cancer screening approaches is expensive, though it could be cost effective for a group of women who may not have inherited the breast cancer susceptibility genes, but who have a familial risk of developing the disease. This is the conclusion of research presented at the eighth European Breast Cancer Conference (EBCC-8) today (Wednesday).
Women who carry the BRCA1/2 gene mutations are known to be at much higher risk of developing breast cancer, and at an early age; for this reason most breast ...
2012-03-22
Hairtrade, the UK's leading retailer of hair extensions, hair care and beauty products has added an exciting new line to its hair styling range.
No Inhibition is a sophisticated hair styling line which consists of a number of products, from smoothing creams, styling gels and shaping pomades to moulding muds, modelling wax and texturizing foams. The elegance of this line is evident in the unique and stylish shaped bottles and colourful chic packaging.
Keven Kou, managing director of I&K International Limited said: "We've been looking for some new and exciting ...
2012-03-22
Vienna, Austria: A Dutch study of the effectiveness of breast cancer screening shows that, even with improved treatments for the disease, population-based mammography programmes still save a significant number of lives.
The finding, presented today (Wednesday) at the eighth European Breast Cancer Conference (EBCC-8) in Vienna, will add further fuel to the debate about whether or not breast cancer screening does more harm than good. Those who argue against national screening programmes say that treatment for the disease is so effective nowadays that the chances of surviving ...
2012-03-22
When observing a fly buzzing around the room, we should have the impression that it is not the fly, but rather the space that lies behind it that is moving. After all, the fly is always fixed in our central point of view. But how does the brain convey the impression of a fly in motion in a motionless field? With the help of functional magnetic resonance imaging (fMRI) scientists from the Werner Reichardt Centre for Integrative Neuroscience and the Max Planck Institute for Biological Cybernetics in Tübingen have identified two areas of the brain that compare the movements ...
2012-03-22
Confused.com has revealed shocking research showing the extent of driver habits on UK roads, with a range of behaviours admitted.
Apparently some drivers across the UK are getting in the driving seat wearing nothing more than pyjamas and with their feet clad in just their slippers or even barefoot. Applying make-up is another part of the morning routine which some women leave until they are actually driving the car: 1 in 10 women put make-up on and drive at the same time and 15% of men have had a shave while driving.
Car insurance experts at Confused.com are warning ...
2012-03-22
Studies in monkeys are unlikely to provide reliable evidence for links between social status and heart disease in humans, according to the first ever systematic review of the relevant research.
The study, published in PLoS ONE, concludes that although such studies are cited frequently in human health research the evidence is often "cherry picked" and generalisation of the findings from monkeys to human societies does not appear to be warranted.
Psychosocial factors such as stress, social instability and work dynamics are often believed to play an important role in ...
2012-03-22
With buds bursting early, only for a mild winter to turn Arctic and wipe them out, we are witnessing how warm weather can trigger flowering, even out of season, and how important it is for plants to blossom at the right time of year.
BBSRC-funded scientists have unpicked why temperature has such a powerful affect on how plants flower. In research to be published in the journal Nature, scientists from the John Innes Centre on the Norwich Research Park have identified the switch that accelerates flowering time in response to temperature.
With warm air, a control gene, ...
LAST 30 PRESS RELEASES:
[Press-News.org] Cancer cells in blood predict chances of survival and can help target breast cancer treatment
